Abstract

Cancer immunotherapy has emerged as a revolutionary approach in the battle against cancer, focusing on harnessing the body's immune system to target and destroy malignant cells. T cells, a critical component of the immune system, play a central role in this therapeutic strategy. This abstract provides a concise overview of the stateof- the-art in Targeting T Cells in Cancer Immunotherapy.